DRESSINGS ACUTE CHRONIC

Brand Owner (click to sort) Address Description
BIOFIL MED Progressive Wound Care Technologies 1212 E Montgomery Xrd, Unit C Savannah GA 31406 Dressings for acute and chronic wounds.; Medical cleansers for skin and wounds;BIOFIL MEDICAL;MED;
BIOFILMASE Progressive Wound Care Technologies 1212 E Montgomery Xrd, Unit C Savannah GA 31406 Dressings for acute and chronic wounds.; Medical cleansers for skin and wounds;
BIOTEX Progressive Wound Care Technologies 1212 E Montgomery Xrd, Unit C Savannah GA 31406 Dressings for acute and chronic wounds;
COLLATEK Human BioSciences, Inc. 940 Clopper Road Gaithersburg MD 20878 Dressings for acute and chronic wounds, burns, surgical wounds; Wound dressings;
COMFORCAP Progressive Wound Care Technologies 1212 E Montgomery Xrd, Unit C Savannah GA 31406 Dressings for acute and chronic wounds namely negative pressure wound therapy dressings with tubing unions;COMFORT CAP;
GELTEX Progressive Wound Care Technologies 1212 E Montgomery Xrd, Unit C Savannah GA 31406 Dressings for acute and chronic wounds;
GUIDED BY DNA, DRIVEN BY PATIENTS Progressive Wound Care Technologies 1212 E Montgomery Xrd, Unit C Savannah GA 31406 Dressings for acute and chronic wounds;Printed publications, namely, brochures, pamphlets, magazines and printed reports and newsletters on health-related topics;Diagnostic testing and screening services, namely, molecular testing for medical purposes, predictive medical tests, personalized medical tests, sequencing-based tests for medical purposes, genotyping for medical purposes and medical reporting services;
MEDIFIL Human BioSciences, Inc. 940 Clopper Road Gaithersburg MD 20878 Dressings for acute and chronic wounds, burns, surgical wounds; Wound dressings;
SKINTEMP Human BioSciences, Inc. 940 Clopper Road Gaithersburg MD 20878 Dressings for acute and chronic wounds, burns, surgical wounds; Wound dressings;SKIN TEMP;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. The invention relates to novel dihydropyridinone derivatives, processes for their preparation, and their use in medicaments, especially for the treatment of chronic obstructive pulmonary diseases, acute coronary syndrome, acute myocardial infarction and heart failure development.